Abstract
Microdialysis (μD) has been established as a reliable in vivo tool to measure interstitial drug concentrations quasi online in virtually every given tissue and organ in animals and humans. Following its first description in the 1970s μD has been further developed and employed as a research and drug development tool in >14,000 PubMed publications. The rationale for the application of μD in Pharma R&D is based on the presence of blood to tissue barriers which hamper drug penetration to target sites. A clear understanding of target site pharmacokinetics (PK), as provided by μD and complementary techniques is a prerequisite for understanding drug action in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson C, Andersson T, Molander M (1991) Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol 71:389–393
Anderson C, Andersson T, Wårdell K (1994) Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 102:807–811
Ao X, Stenken JA (2006) Microdialysis sampling of cytokines. Methods 38:331–341
Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordström CH, Robertson C, Sahuquillo J, Smith M, Stocchetti N, Ungerstedt U, Unterberg A, Olsen NV (2004) Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 30:2166–2169
Benfeldt E, Groth L (1998) Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 78:274–278
Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, Holtzman DM (2011) Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat Neurosci 14:750–756
Bolinder J, Ungerstedt U, Arner P (1993) Long term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet 342:1080–1085
Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, Holtzman DM (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321:1221–1224
Brunner M, Langer O, Dobrozemsky G, Müller U, Zeitlinger M, Mitterhauser M, Wadsak W, Dudczak R, Kletter K, Müller M (2004) [18F]Ciprofloxacin, a new PET tracer for non-invasive assessment of ciprofloxacin tissue pharmacokinetics in humans. Antimicrobial Agents Chemother 48:3850–3857
Brunner M, Müller M (2007) Microdialysis in clinical drug delivery studies. In: Westerink BH, Cremers TI (eds) Handbook of microdialysis. Elsevier, pp 625–644
Carneheim C, Ståhle L (1991) Microdialysis of lipophilic compounds: a methodological study. Pharmacol Toxicol 69:378–380
Chaurasia CS (1999) In vivo microdialysis sampling: theory and applications. Biomed Chromatogr 13:317–332
Chaurasia CS, Müller M, Benfeldt E, Sawchuk RJ, Cheung WY, Elmquist WF, Bungay PM, Derendorf H, DeLange ECM, Lunte CE, Hammarlund-Udenaes M, Bolinder J, Bullock R, Kellogg DL, Joukhadar C, Henrik Nordstrom C, Rollema H, Welty DF, Yeo H, Stahle L, Bashaw ED, Shah VP, Ungerstedt U (2007) AAPS-FDA Workshop white paper: microdialysis principles, application and regulatory perspectives. J Clin Pharmacol 47:589–603
Clinckers R, Smolders I, Vermoesen K, Michotte Y, Danhof M, Voskuyl R, Della Pasqua O (2009) Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations. Expert Opin Drug Metab Toxicol 5:1267–1277
Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240–246
Clough GF (2005) Microdialysis of large molecules. AAPS J 7:E686–E692
Cross SE, Anderson C, Thompson MJ, Roberts MS (1997) Is there tissue penetration after application of topical salicylate formulations? Lancet 350:636
Davies MI, Cooper JD, Desmond SS, Lunte CE, Lunte SM (2000) Analytical considerations for microdialysis sampling. Adv Drug Deliv Rev 45:169–188
Delacher S, Derendorf H, Hollenstein U, Brunner M, Joukhadar C, Hofmann S, Georgopoulos A, Eichler HG, Müller M (2000) An in vivo PK—in vitro PD model to simulate antibiotic activity at the target site. J Antimicrob Agents Chemother 46:733–739
de Lange EC, de Boer AG, Breimer DD (2000) Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev 45:125–148
Duo J, Fletcher H, Stenken JA (2006) Natural and synthetic affinity agents as microdialysis sampling mass transport enhancers: current progress and future perspectives. Biosens Bioelectron 22:449–457
During MJ, Spencer DD (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607–1610
Enblad P, Valtysson J, Andersson J, Lilja A, Valind S, Antoni G, Långström B, Hillered L, Persson L (1996) Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab 16:637–644
Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 8:344–356
Eichler HG, Müller M (1998) Drug distribution—the forgotten relative of clinical pharmacokinetics. Clin Pharmacokinet 34:95–99
Elmquist WF, Sawchuk RJ (1997) Application of microdialysis in pharmacokinetic studies. Pharm Res 14:267–288
Fettweis G, Borlak J (1996) Topics in xenobiochemistry—application of microdialysis techniques in pharmacokinetic studies. Xenobiotica 26:473–485
Fischman AJ, Alpert NM, Rubin RH (2002) Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action. Clin Pharmacokinet 41:581–602
Fried I, Wilson CL, Morrow JW, Cameron KA, Behnke ED, Ackerson LC, Maidment NT (2001) Increased dopamine release in the human amygdala during performance of cognitive tasks. Nat Neurosci 4:201–206
Hansen DK, Davies MI, Lunte SM, Lunte CE (1999) Pharmacokinetic and metabolism studies using microdialysis sampling. J Pharm Sci 88:14–27
Herbaugh AW, Stenken JA (2011) Antibody-enhanced microdialysis collection of CCL2 from rat brain. J Neurosci Methods 202:124–127
Herkner H, Müller MR, Kreischitz N, Mayer BX, Frossard M, Joukhadar C, Klein N, Lackner E, Müller M (2002) Closed chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Resp Crit Care Med 165:273–276
Hillered L, Persson L (1999) Neurochemical monitoring of the acutely injured human brain. Scand J Clin Lab Invest Suppl 229:9–18
Hillman J, Aneman O, Anderson C, Sjögren F, Säberg C, Mellergård P (2005) A microdialysis technique for routine measurement of macromolecules in the injured human brain. Neurosurgery 56:1264–1268
Höcht C, Opezzo JA, Bramuglia GF, Taira CA (2006) Application of microdialysis in clinical pharmacology. Curr Clin Pharmacol 1:163–183
Holmgaard R, Nielsen JB, Benfeldt E (2010) Microdialysis sampling for investigations of bioavailability and bioequivalence of topically administered drugs: current state and future perspectives. Skin Pharmacol Physiol 23:225–243
Holmgaard R, Benfeldt E, Nielsen JB, Gatschelhofer C, Sorensen JA, Höfferer C, Bodenlenz M, Pieber TR, Sinner F (2012) Comparison of open-flow microperfusion and microdialysis methodologies when sampling topically applied fentanyl and benzoic acid in human dermis ex vivo. Pharm Res 29:1808–1820
Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am 271:58–65
Jansson PA, Fowelin JP, von Schenck HP, Smith UP, Lönnroth PN (1993) Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 42:1469–1473
Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Mimmack M, Ohkura S (1997) Formation of olfactory memories mediated by nitric oxide. Nature 388:670–674
Kennergren C, Mantovani V, Lönnroth P, Nystrom B, Berglin E, Hamberger A (1999) Monitoring of extracellular aspartate aminotransferase and troponin T by microdialysis during and after cardioplegic heart arrest. Cardiology 92:162–170
Kreilgaard M (2002) Assessment of cutaneous drug delivery using microdialysis. Adv Drug Deliv Rev 54(Suppl 1):S99–S121
Kurosaki Y, Nakamura S, Shiojiri Y, Kawasaki H (1998) Lipo-microdialysis: a new microdialysis method for studying the pharmacokinetics of lipophilic substances. Biol Pharm Bull 21:194–196
Langer O, Brunner M, Karch R, Müller U, Dobrozemsky G, Abrahim A, Paul M, Zeitlinger M, Joukhadar C, Dudczak R, Kletter K, Müller M (2005) Combined positron emission tomography and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med 46:1835–1841
Li Y, Peris J, Zhong L, Derendorf H (2006) Microdialysis as a tool in local pharmacodynamics. AAPS J 8:E222–E235
Lönnroth P, Jansson PA, Smith U (1987) A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 253:E228–E231
Lunte SM, Lunte CE (1996) Microdialysis sampling for pharmacological studies: HPLC and CE analysis. Adv Chromatogr 36:383–432
Matthews PM, Rabiner EA, Passchier J, Gunn RN (2012) Positron emission tomography molecular imaging for drug development. Br J Clin Pharmacol 73:175–186
Maurer MH, Haux D, Unterberg AW, Sakowitz OW (2008) Proteomics of human cerebral microdialysate: from detection of biomarkers to clinical application. Proteomics Clin Appl 2:437–443
Müller M, Schmid R, Wagner O, Osten BV, Shayganfar H, Eichler HG (1995) In vivo characterization of transdermal drug transport by microdialysis. J Controlled Release 37:49–57
Müller M, Haag O, Burgdorff T, Georgopoulos A, Weninger W, Jansen B, Stanek G, Pehamberger H, Agneter E, Eichler HG (1996a) Characterization of peripheral compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 40:2703–2709
Müller M, Holmäng A, Anderson OK, Eichler HG, Lönnroth P (1996b) Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance test. Am J Physiol 271:E1003–E1007
Müller M, Mader RM, Steiner B, Steger GG, Jansen B, Gnant M, Helbich T, Jakesz R, Eichler HG, Blöchl-Daum B (1997a) 5-Fluorouracil kinetics in the interstitial tumor space and clinical response in breast cancer patients. Cancer Res 57:2598–2601
Müller M, Burgdorff T, Jansen B, Singer EA, Agneter E, Dorner G, Brunner M, Eichler HG (1997b) In vivo drug-response measurements in target tissues by microdialysis. Clin Pharmacol Ther 62:165–170
Müller M (2000) Microdialysis in clinical drug delivery studies. Adv Drug Deliv Rev 45:255–269
Müller M (2002) Science, medicine and the future: microdialysis. BMJ 324:588–591
Müller M, delaPena A, Derendorf H (2004) Issues in PK-PD of antibiotics: tissue penetration. Antimicrobial Agents Chemother 48:1441–1453
Müller M (2009) Monitoring tissue drug levels by microdialysis. Altern Lab Anim 37:57–59
Nandi P, Lunte SM (2009) Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. Anal Chim Acta 651:1–14
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671
Schmidt S, Banks R, Kumar V, Rand KH, Derendorf H (2008) Clinical microdialysis in skin and soft tissues: an update. J Clin Pharmacol 48:351–364
Shingaki T, Takashima T, Wada Y, Tanaka M, Kataoka M, Ishii A, Shigihara Y, Sugiyama Y, Yamashita S, Watanabe Y (2012) Imaging of gastrointestinal absorption and biodistribution of an orally administered probe using positron emission tomography in humans. Clin Pharmacol Ther 91:653–659
Shah VP (2004) Topical drug products—microdialysis: regulatory perspectives. Int J Clin Pharmacol Ther 42:379–381
Stahl M, Bouw R, Jackson A, Pay V (2002) Human microdialysis. Curr Pharm Biotechnol 3:165–178
Ståhle L, Arner P, Ungerstedt U (1991) Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man. Life Sci 49:1853–1858
Ungerstedt U, Pycock C (1974) Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss 30:44–55
Ungerstedt U (1991) Microdialysis—principles and applications for studies in animals and man. J Intern Med 230:365–373
Van Eeckhaut A, Maes K, Aourz N, Smolders I, Michotte Y (2011) The absolute quantification of endogenous levels of brain neuropeptides in vivo using LC-MS/MS. Bioanalysis 3:1271–1285
Whitaker G, Lunte CE (2010) Investigation of microdialysis sampling calibration approaches for lipophilic analytes: doxorubicin. J Pharm Biomed Anal 53:490–496
Yang Z, Brundage RC, Barbhaiya RH, Sawchuk RJ (1997) Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat. Pharm Res 14:865–872
Zeitlinger MA, Derendorf H, Mouton JW, Cars O, Craig WA, Andes D, Theuretzbacher U (2011) Protein binding: do we ever learn? Antimicrob Agents Chemother 55:3067–3074
Zhou Q, Gallo JM (2005) In vivo microdialysis for PK and PD studies of anticancer drugs. AAPS J 7:E659–E667
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Müller, M. (2013). Introduction to the Microdialysis Technology. In: Müller, M. (eds) Microdialysis in Drug Development. AAPS Advances in the Pharmaceutical Sciences Series, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4815-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4815-0_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4814-3
Online ISBN: 978-1-4614-4815-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)